Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Vaccines|November 26, 2024
B and T Cell Bi-Cistronic Multiepitopic Vaccine Induces Broad Immunogenicity and Provides Protection Against SARS-CoV-2Beatriz Perdiguero, Enrique Álvarez, Laura Marcos-Villar, et al.The Journal of Biological Chemistry|July 31, 2014
Activation of the double-stranded RNA-dependent protein kinase PKR by small ubiquitin-like modifier (SUMO)Carlos F de la Cruz-Herrera, Michela Campagna, Maria A García, et al.Journal of Virology|November 2, 2012
Rotavirus viroplasm proteins interact with the cellular SUMOylation system: implications for viroplasm-like structure formationMichela Campagna, Laura Marcos-Villar, Francesca Arnoldi, et al.Cell Cycle (Georgetown, Tex.)|August 23, 2013
SUMOylation of p53 mediates interferon activitiesLaura Marcos-Villar, José V Pérez-Girón, Jéssica M Vilas, et al.Vaccines|July 30, 2025
ISG15 as a Potent Immune Adjuvant in MVA-Based Vaccines Against Zika Virus and SARS-CoV-2Juan García-Arriaza, Michela Falqui, Patricia Pérez, et al.Frontiers in Immunology|May 21, 2026
Preclinical evaluation of a multi-epitope mRNA vaccine platform for broad and durable SARS-CoV-2 protectionLaura Marcos-Villar, Beatriz Perdiguero, Laura Sin, et al.Frontiers in Immunology|July 5, 2023
Immunogenicity and efficacy of a novel multi-patch SARS-CoV-2/COVID-19 vaccine candidateBeatriz Perdiguero, Laura Marcos-Villar, María López-Bravo, et al.NPJ Vaccines|March 6, 2024
Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA ConsortiumLaura Marcos-Villar, Beatriz Perdiguero, Shubaash Anthiya, et al.Emerging Microbes & Infections|August 1, 2024
Heterologous mRNA/MVA delivering trimeric-RBD as effective vaccination regimen against SARS-CoV-2: COVARNA ConsortiumLaura Marcos-Villar, Beatriz Perdiguero, María López-Bravo, et al.Pageof 3